Dear Sir,Please find Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the Quarter ended on December 31, 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Omkar Pharmachem Ltd. on 6ix
Earlier from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Jan 07 2026
- Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025
- Omkar Pharmachem Ltd. Press Release Dec 29 2025
- Closure of Trading Window
- Results- Unaudited Financial Results For September, 2025
Later from Omkar Pharmachem
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.
- Omkar Pharmachem Ltd. Press Release Jan 27 2026
- Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025
- Omkar Pharmachem Ltd. Press Release Feb 04 2026
- Omkar Pharmachem Ltd. Press Release Feb 12 2026
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem